T1	DISO 234 266	acontecimientos cardiovasculares
T2	CHEM 156 160	IL-6
#1	AnnotatorNotes T2	C0021760; interleukin-6; Amino Acid, Peptide, or Protein · Immunologic Factor | C1698754; IL6 protein, human; Amino Acid, Peptide, or Protein · Biologically Active Substance | C2983957; interleukin-6, human; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	CHEM 166 177	tocilizumab
#2	AnnotatorNotes T3	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	CHEM 198 208	etanercept
#3	AnnotatorNotes T4	C0717758; etanercept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T5	CHEM 210 213	ETA
T6	ANAT 250 266	cardiovasculares
#4	AnnotatorNotes T6	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T7	DISO 284 303	artritis reumatoide
#5	AnnotatorNotes T7	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T8	DISO 305 307	AR
#6	AnnotatorNotes T8	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T9	CHEM 361 370	Roactemra
#7	AnnotatorNotes T9	C3272237; Roactemra; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T10	CHEM 371 378	Actemra
#8	AnnotatorNotes T10	C2740854; Actemra; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T11	CHEM 380 391	tocilizumab
#9	AnnotatorNotes T11	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T12	CHEM 407 413	Enbrel
#10	AnnotatorNotes T12	C0720193; Enbrel; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T13	CHEM 415 425	etanercept
#11	AnnotatorNotes T13	C0717758; etanercept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T14	DISO 444 463	artritis reumatoide
#12	AnnotatorNotes T14	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T15	DISO 465 467	AR
#13	AnnotatorNotes T15	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T16	DISO 497 519	enfermedades cardiacas
#14	AnnotatorNotes T16	C0018799; Heart Diseases; Disease or Syndrome
T17	ANAT 510 519	cardiacas
#15	AnnotatorNotes T17	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T18	DISO 545 564	Artritis Reumatoide
#16	AnnotatorNotes T18	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T19	DISO 566 568	AR
#17	AnnotatorNotes T19	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T20	DISO 645 647	AR
#18	AnnotatorNotes T20	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T21	DISO 812 849	enfermedad de las arterias coronarias
#19	AnnotatorNotes T21	C1956346; Coronary Artery Disease; Disease or Syndrome
T22	DISO 851 854	EAC
#20	AnnotatorNotes T22	C1956346; Coronary Artery Disease; Disease or Syndrome
T23	DISO 870 880	tabaquismo
#21	AnnotatorNotes T23	C0040336; Tobacco Use Disorder; Mental or Behavioral Dysfunction | C0425291; Tobacco smoking consumption; Finding | C1306274; Tabagism; Mental or Behavioral Dysfunction
T24	DISO 901 913	hipertensión
#22	AnnotatorNotes T24	C0020538; Hypertensive disease; Disease or Syndrome
T25	CHEM 915 929	colesterol HDL
#23	AnnotatorNotes T25	C0023822; High Density Lipoprotein Cholesterol; Biologically Active Substance · Organic Chemical
T26	DISO 963 966	EAC
#24	AnnotatorNotes T26	C1956346; Coronary Artery Disease; Disease or Syndrome
T27	DISO 975 983	diabetes
#25	AnnotatorNotes T27	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T28	DISO 998 1023	enfermedad extraarticular
T29	DISO 1038 1040	AR
#26	AnnotatorNotes T29	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T30	PROC 1069 1082	Cirugía mayor
#27	AnnotatorNotes T30	C0679637; major surgery; Therapeutic or Preventive Procedure
T31	PROC 1128 1141	cirugía mayor
#28	AnnotatorNotes T31	C0679637; major surgery; Therapeutic or Preventive Procedure
T32	DISO 1196 1227	Enfermedad reumática autoinmune
T33	DISO 1243 1245	AR
#29	AnnotatorNotes T33	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T34	DISO 1277 1322	enfermedad inflamatoria de las articulaciones
#30	AnnotatorNotes T34	C0683381; inflammatory joint disease; Disease or Syndrome
T35	ANAT 1308 1322	articulaciones
#31	AnnotatorNotes T35	C0022417; Joints; Body Space or Junction | C1269611; Entire joint; Body Space or Junction
T36	DISO 1338 1340	AR
#32	AnnotatorNotes T36	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T37	DISO 1400 1443	enfermedad cerebrovascular o cardiovascular
T38	ANAT 1429 1443	cardiovascular
#33	AnnotatorNotes T38	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T39	DISO 1478 1480	IM
#34	AnnotatorNotes T39	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T40	PROC 1482 1499	revascularización
#35	AnnotatorNotes T40	C0581603; Revascularization - action; Therapeutic or Preventive Procedure
T41	DISO 1501 1536	accidente cerebrovascular isquémico
#36	AnnotatorNotes T41	C0948008; Ischemic stroke; Disease or Syndrome
T42	DISO 1538 1566	ataque isquémico transitorio
#37	AnnotatorNotes T42	C0007787; Transient Ischemic Attack; Disease or Syndrome
T43	DISO 1569 1593	síndrome coronario agudo
#38	AnnotatorNotes T43	C0948089; Acute Coronary Syndrome; Disease or Syndrome
T44	CHEM 179 182	TCZ
#39	AnnotatorNotes T44	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T45	CHEM 125 154	receptor de la interleucina 6
T46	CHEM 745 763	FARME no biológico
#40	AnnotatorNotes T46	C4054347; Non-Biologic Disease-Modifying Antirheumatic Drug; Pharmacologic Substance
T47	ANAT 830 849	arterias coronarias
#41	AnnotatorNotes T47	C0205042; Coronary artery; Body Part, Organ, or Organ Component + C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T48	DISO 915 934	colesterol HDL bajo
#42	AnnotatorNotes T48	C2874290; Depressed HDL cholesterol; Finding [ICD-10: E78.6]
T49	ANAT 1578 1587	coronario
#43	AnnotatorNotes T49	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T50	Date 12 16	2010
T51	LIVB 270 279	pacientes
#44	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	LIVB 430 439	pacientes
#45	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	Spec_cue 482 488	riesgo
T54	LIVB 598 605	Hombres
#46	AnnotatorNotes T54	C0025266; Male population group; Population Group
T55	LIVB 608 615	mujeres
#47	AnnotatorNotes T55	C0043210; Woman; Population Group
T56	Age 620 627	50 años
T57	LIVB 631 640	Pacientes
#48	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	Duration 660 669	> 6 meses
T61	Date 882 898	en la actualidad
T62	Duration 1086 1099	las 8 semanas
T63	Duration 1169 1175	un año
T64	Date 1354 1360	actual
T65	Date 1363 1371	reciente
T66	Duration 1376 1395	los últimos 3 meses
T69	Duration 1555 1566	transitorio
#49	AnnotatorNotes T69	C0205374; Transitory; Temporal Concept
T59	Neg_cue 1323 1334	distinta de
T60	Neg_cue 1228 1239	distinta de
T67	PROC 690 696	visita
#50	AnnotatorNotes T67	C1512346; Patient Visit; Health Care Activity
T68	Quantifier_or_Qualifier 697 704	inicial
A1	Assertion T16 Speculated
A2	Assertion T36 Negated
A3	Status T26 Family_history_of
A4	Status T30 History_of
A5	Assertion T33 Negated
A6	Status T34 History_of
A7	Status T36 History_of
A8	Status T37 History_of
A9	Status T39 History_of
A10	Status T40 History_of
A11	Status T41 History_of
A12	Status T42 History_of
A13	Status T43 History_of
#52	AnnotatorNotes T61	C0521116; Current (present time); Temporal Concept 
#53	AnnotatorNotes T64	C0521116; Current (present time); Temporal Concept 
#54	AnnotatorNotes T45	C0063717; Interleukin 6 Receptor; Amino Acid, Peptide, or Protein · Immunologic Factor · Receptor 
#55	AnnotatorNotes T1	C1320716; Cardiovascular event; Finding
#56	AnnotatorNotes T5	C0717758; etanercept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
#57	AnnotatorNotes T37	C0007820; Cerebrovascular Disorders; Disease or Syndrome + C0007222; Cardiovascular Diseases; Disease or Syndrome
#58	AnnotatorNotes T65	C0332185; Recent; Temporal Concept
T70	Quantifier_or_Qualifier 754 763	biológico
A14	Assertion T70 Negated
T71	Neg_cue 751 753	no
T72	CONC 1467 1476	controlar
A15	Assertion T72 Negated
T73	Neg_cue 1463 1466	sin
R1	Speculation Arg1:T53 Arg2:T16	
R2	Negation Arg1:T71 Arg2:T70	
T74	Observation 790 808	factores de riesgo
#51	AnnotatorNotes T74	C0035648; risk factors; Finding
R3	Negation Arg1:T60 Arg2:T33	
R4	Negation Arg1:T59 Arg2:T36	
R5	Negation Arg1:T73 Arg2:T72	
T75	Observation 101 108	efectos
#59	AnnotatorNotes T75	C1518681; Outcome of Therapy; Finding (?)
R6	Location_of Arg1:T6 Arg2:T1	
R7	Experiences Arg1:T51 Arg2:T75	
R8	Experiences Arg1:T51 Arg2:T1	
R9	Experiences Arg1:T51 Arg2:T7	
R10	Experiences Arg1:T51 Arg2:T8	
T76	Quantifier_or_Qualifier 312 328	moderada a grave
#60	AnnotatorNotes T76	C1299393; Moderate to severe; Qualitative Concept
R11	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T76	
R12	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T76	
R13	Location_of Arg1:T17 Arg2:T16	
R14	Experiences Arg1:T51 Arg2:T3	
R15	Experiences Arg1:T51 Arg2:T44	
R16	Experiences Arg1:T51 Arg2:T4	
R17	Experiences Arg1:T51 Arg2:T5	
R19	Experiences Arg1:T52 Arg2:T9	
R20	Experiences Arg1:T52 Arg2:T11	
R21	Experiences Arg1:T52 Arg2:T12	
R22	Experiences Arg1:T52 Arg2:T13	
R23	Experiences Arg1:T52 Arg2:T14	
R24	Experiences Arg1:T52 Arg2:T15	
R18	Experiences Arg1:T52 Arg2:T10	
T78	Observation 482 496	riesgo alto de
#62	AnnotatorNotes T78	C0332167; High risk of; Finding
R25	Before Arg1:T78 Arg2:T16	
R26	Experiences Arg1:T52 Arg2:T78	
R27	Has_Age Arg1:T54 Arg2:T56	
R28	Has_Age Arg1:T55 Arg2:T56	
R29	Experiences Arg1:T57 Arg2:T20	
R30	Has_Duration_or_Interval Arg1:T20 Arg2:T58	
R31	Overlap Arg1:T20 Arg2:T67	
R32	Has_Quantifier_or_Qualifier Arg1:T67 Arg2:T68	
#63	AnnotatorNotes T68	C0205265; Initially; Temporal Concept
T79	Observation 708 728	Respuesta inadecuada
#64	AnnotatorNotes T79	C0858218; Inappropriate drug response; Finding
R33	Overlap Arg1:T79 Arg2:T46	
R34	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T70	
#65	AnnotatorNotes T70	C0205460; biological; Qualitative Concept 
T80	Quantifier_or_Qualifier 732 744	al menos, un
R35	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T80	
T81	Quantifier_or_Qualifier 780 789	uno o más
R36	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T81	
R37	Location_of Arg1:T47 Arg2:T21	
R38	Location_of Arg1:T47 Arg2:T22	
R39	Overlap Arg1:T74 Arg2:T21	
R40	Overlap Arg1:T74 Arg2:T22	
R41	Before Arg1:T23 Arg2:T22	
R42	Before Arg1:T23 Arg2:T21	
R43	Overlap Arg1:T23 Arg2:T61	
R44	Before Arg1:T24 Arg2:T21	
R45	Before Arg1:T48 Arg2:T21	
R46	Before Arg1:T26 Arg2:T21	
R47	Before Arg1:T27 Arg2:T21	
R48	Overlap Arg1:T28 Arg2:T29	
R49	Before Arg1:T28 Arg2:T21	
T82	Quantifier_or_Qualifier 967 973	precoz
A16	Status T82 History_of
#66	AnnotatorNotes T82	C1279930; Precocious; Temporal Concept
R50	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T82	
#67	AnnotatorNotes T28	C0263741; Extra-articular rheumatoid process; Disease or Syndrome (?)
R51	Overlap Arg1:T31 Arg2:T63	
T83	CONC 1186 1192	inicio
#68	AnnotatorNotes T83	C4684789; Study Start; Temporal Concept | C2349982; Study start time; Temporal Concept
R52	Before Arg1:T31 Arg2:T83	
T84	PROC 1116 1125	selección
#69	AnnotatorNotes T84	C0242802; Patient Selection; Research Activity
R53	Overlap Arg1:T30 Arg2:T62	
R54	Before Arg1:T30 Arg2:T84	
T85	Quantifier_or_Qualifier 1142 1153	planificada
#70	AnnotatorNotes T85	C0205539; Scheduled - procedure status; Qualitative Concept
R55	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T85	
#71	AnnotatorNotes T32	C1328842; autoimmune rheumatologic disease; Disease or Syndrome
R56	Location_of Arg1:T35 Arg2:T34	
R57	Overlap Arg1:T37 Arg2:T64	
R58	Overlap Arg1:T37 Arg2:T65	
R59	Overlap Arg1:T37 Arg2:T66	
R60	Location_of Arg1:T38 Arg2:T37	
R61	Overlap Arg1:T39 Arg2:T64	
R62	Overlap Arg1:T39 Arg2:T65	
R63	Overlap Arg1:T40 Arg2:T64	
R64	Overlap Arg1:T40 Arg2:T65	
R65	Overlap Arg1:T41 Arg2:T64	
R66	Overlap Arg1:T41 Arg2:T65	
R67	Overlap Arg1:T42 Arg2:T64	
R68	Overlap Arg1:T42 Arg2:T65	
R69	Has_Duration_or_Interval Arg1:T42 Arg2:T69	
R70	Overlap Arg1:T43 Arg2:T64	
R71	Overlap Arg1:T43 Arg2:T65	
R72	Location_of Arg1:T49 Arg2:T43	
T86	Quantifier_or_Qualifier 1444 1456	concomitante
#72	AnnotatorNotes T86	C0521115; Simultaneous; Temporal Concept
R73	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T86	
A17	Status T86 History_of
T87	Quantifier_or_Qualifier 1457 1462	grave
A18	Status T87 History_of
#73	AnnotatorNotes T87	C1547227; Severe - Severity of Illness Code; Intellectual Product
R74	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T87	
R75	Overlap Arg1:T39 Arg2:T66	
R76	Overlap Arg1:T40 Arg2:T66	
R77	Overlap Arg1:T41 Arg2:T66	
R78	Overlap Arg1:T42 Arg2:T66	
R79	Overlap Arg1:T43 Arg2:T66	
R80	Causes Arg1:T3 Arg2:T75	
R81	Causes Arg1:T44 Arg2:T75	
R82	Causes Arg1:T4 Arg2:T75	
R83	Causes Arg1:T5 Arg2:T75	
R84	Experiences Arg1:T52 Arg2:T16	
R85	Overlap Arg1:T1 Arg2:T7	
R86	Overlap Arg1:T1 Arg2:T8	
R87	Overlap Arg1:T14 Arg2:T78	
R88	Overlap Arg1:T15 Arg2:T78	
A19	Status T31 Future
A20	Experiencer T51 Patient
A21	Experiencer T52 Patient
A22	Experiencer T55 Patient
A23	Experiencer T54 Patient
A24	Experiencer T57 Patient
